Showing results (2011-2020 of 8,878) with videos related to

Sort By:
Pageof 888
BJU International|October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapyBart Geboers, Dennie Meijer, William Counter, et al.
BJU International|March 27, 2024
Interaction of patient age and high-grade prostate cancer on targeted biopsies of MRI suspicious lesionsJamie S Pak, Richard Huang, William C Huang, et al.
BJU International|September 11, 2023
Barriers and enablers of active surveillance for prostate cancer: a qualitive study of cliniciansTrent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, et al.
BJU International|September 5, 2023
Retrospective first-in-human use of the LithoVue™ Elite ureteroscope to measure intrarenal pressureNaeem Bhojani, Kyo Chul Koo, Kahina Bensaadi, et al.
BJU International|September 5, 2023
Methodological rigour in preclinical urology: a systematic review reporting research quality over a 14-year periodSeung Hyun Park, Se Bee Lee, Seoyeon Park, et al.
BJU International|September 1, 2023
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi-institutional analysis of 120 consecutive patientsStefanie M Croghan, Eoghan M Cunnane, Sorcha O'Meara, et al.
BJU International|August 7, 2023
Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre studyMarc A Furrer, Niranjan Sathianathen, Brigitta Gahl, et al.
BJU International|August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapyDaniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
BJU International|November 27, 2023
Post-prostatectomy incontinence: a guideline of guidelinesNikita R Bhatt, Aswathy Pavithran, Cristian Ilie, et al.
BJU International|November 27, 2023
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinomaXin An, Cong Xue, Meiting Chen, et al.
Pageof 888